Tirzepatide is an innovative once-weekly injectable medication that mimics two key gut hormones—GLP-1 and GIP—to effectively manage type 2 diabetes and support significant weight loss. By regulating blood sugar, slowing digestion, and reducing appetite, it helps patients achieve better glycemic control and sustainable weight reduction when combined with diet and exercise. Approved for adults with obesity or overweight with weight-related conditions, Tirzepatide (Mounjaro/Zepbound) has shown impressive results in clinical studies, often outperforming single-hormone treatments. Common side effects include nausea, diarrhea, vomiting, constipation, and decreased appetite, which typically improve over time. Consult your healthcare provider to see if Tirzepatide is right for you.